178 related articles for article (PubMed ID: 24922518)
1. Circulating mediators of inflammation and immune activation in AIDS-related non-hodgkin lymphoma.
Nolen BM; Breen EC; Bream JH; Jenkins FJ; Kingsley LA; Rinaldo CR; Lokshin AE
PLoS One; 2014; 9(6):e99144. PubMed ID: 24922518
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of cytokines and biomarkers for inflammation and immune activation, and HIV-associated non-Hodgkin B-cell lymphoma risk.
Vendrame E; Hussain SK; Breen EC; Magpantay LI; Widney DP; Jacobson LP; Variakojis D; Knowlton ER; Bream JH; Ambinder RF; Detels R; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):343-9. PubMed ID: 24220912
[TBL] [Abstract][Full Text] [Related]
3. Serum biomarkers of immune activation and subsequent risk of non-hodgkin B-cell lymphoma among HIV-infected women.
Hussain SK; Hessol NA; Levine AM; Breen EC; Anastos K; Cohen M; D'Souza G; Gustafson DR; Silver S; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2084-93. PubMed ID: 24045923
[TBL] [Abstract][Full Text] [Related]
4. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma.
Breen EC; Hussain SK; Magpantay L; Jacobson LP; Detels R; Rabkin CS; Kaslow RA; Variakojis D; Bream JH; Rinaldo CR; Ambinder RF; Martinez-Maza O
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1303-14. PubMed ID: 21527584
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.
Thapa DR; Hussain SK; Tran WC; Dʼsouza G; Bream JH; Achenback CJ; Ayyavoo V; Detels R; Martínez-Maza O
J Acquir Immune Defic Syndr; 2014 Jun; 66(2):229-37. PubMed ID: 24675587
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk.
Hussain SK; Zhu W; Chang SC; Breen EC; Vendrame E; Magpantay L; Widney D; Conn D; Sehl M; Jacobson LP; Bream JH; Wolinsky S; Rinaldo CR; Ambinder RF; Detels R; Zhang ZF; Martínez-Maza O
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):295-307. PubMed ID: 23250934
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma.
Epeldegui M; Magpantay L; Guo Y; Halec G; Cumberland WG; Yen PK; Macatangay B; Margolick JB; Rositch AF; Wolinsky S; Martinez-Maza O; Hussain SK
AIDS; 2018 Apr; 32(7):945-954. PubMed ID: 29424776
[TBL] [Abstract][Full Text] [Related]
8. Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study.
Hoffmann C; Hentrich M; Gillor D; Behrens G; Jensen B; Stoehr A; Esser S; van Lunzen J; Krznaric I; Müller M; Oette M; Hensel M; Thoden J; Fätkenheuer G; Wyen C
HIV Med; 2015 Apr; 16(4):261-4. PubMed ID: 25252101
[TBL] [Abstract][Full Text] [Related]
9. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.
Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia RJ; Gold J; Finlayson RJ; Cooper DA; Kaldor JM
AIDS; 2000 Jan; 14(2):133-40. PubMed ID: 10708283
[TBL] [Abstract][Full Text] [Related]
10. Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.
Sei S; O'Neill DP; Stewart SK; Yang Q; Kumagai M; Boler AM; Adde MA; Zwerski SL; Wood LV; Venzon DJ; Magrath IT
Cancer Res; 2001 Jul; 61(13):5028-37. PubMed ID: 11431337
[TBL] [Abstract][Full Text] [Related]
11. Circulating serum free light chains as predictive markers of AIDS-related lymphoma.
Landgren O; Goedert JJ; Rabkin CS; Wilson WH; Dunleavy K; Kyle RA; Katzmann JA; Rajkumar SV; Engels EA
J Clin Oncol; 2010 Feb; 28(5):773-9. PubMed ID: 20048176
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of soluble CD23 (sCD23) precede the appearance ofacquired immunodeficiency syndrome--associated non-Hodgkin's lymphoma.
Yawetz S; Cumberland WG; van der Meyden M; Martínez-Maza O
Blood; 1995 Apr; 85(7):1843-9. PubMed ID: 7703491
[TBL] [Abstract][Full Text] [Related]
14. Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.
Chao C; Xu L; Abrams D; Leyden W; Horberg M; Towner W; Klein D; Tang B; Silverberg M
AIDS; 2010 Jul; 24(11):1765-70. PubMed ID: 20453630
[TBL] [Abstract][Full Text] [Related]
15. Associations of Viral Seroreactivity with AIDS-Related Non-Hodgkin Lymphoma.
Song M; Bassig BA; Bender N; Goedert JJ; Winkler CA; Brenner N; Waterboer T; Rabkin CS
AIDS Res Hum Retroviruses; 2020 May; 36(5):381-388. PubMed ID: 31789046
[TBL] [Abstract][Full Text] [Related]
16. Increasing Levels of Serum Heat Shock Protein 70 Precede the Development of AIDS-Defining Non-Hodgkin Lymphoma Among Carriers of HLA-B8-DR3.
Aissani B; Martinez-Maza O; Kaslow RA; Wiener HW; Bream JH; Stosor V; Martinson JJ; Jacobson LP; Shrestha S
J Acquir Immune Defic Syndr; 2019 Jul; 81(3):266-273. PubMed ID: 31026237
[TBL] [Abstract][Full Text] [Related]
17. Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era.
Engels EA; Pfeiffer RM; Landgren O; Moore RD
J Acquir Immune Defic Syndr; 2010 May; 54(1):78-84. PubMed ID: 20418723
[TBL] [Abstract][Full Text] [Related]
18. Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.
Sparano JA; Hu X; Wiernik PH; Sarta C; Reddy DM; Hanau L; Henry DH
J Natl Cancer Inst; 1997 Feb; 89(4):301-7. PubMed ID: 9048834
[TBL] [Abstract][Full Text] [Related]
19. TLR2-activated B cells are phenotypically similar to the abnormal circulating B cells seen preceding the diagnosis of AIDS-related NHL diagnosis.
Guo Y; Siewe B; Epeldegui M; Detels R; Landay AL; Martínez-Maza O
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):204-10. PubMed ID: 23722608
[TBL] [Abstract][Full Text] [Related]
20. Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.
Epeldegui M; Martínez-Maza O
For Immunopathol Dis Therap; 2015; 6(1-2):79-90. PubMed ID: 28702272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
